Differential expression of intercellular adhesion molecule-1 (ICAM-1) in the Aβ-containing lesions in brains of patients with dementia of the Alzheimer type

Acta Neuropathologica

Volumn 91, Issue 6, 1996, Pages 608-615

  Verbeek, Marcel M ^a   Irene, Otte Höller Pieter ^b   Wesseling, Peter ^a   Ruiter, Dirk J ^a   De Waal, Robert M W ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Alzheimer's disease; Cerebellum; Cerebrovascular; Inflammation; Intercellular adhesion molecule 1

Indexed keywords

AMYLOID BETA PROTEIN; INTERCELLULAR ADHESION MOLECULE 1;

ADULT; AGED; ALZHEIMER DISEASE; AMYLOIDOSIS; ARTICLE; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; ENCEPHALITIS; FEMALE; GRANULE CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PURKINJE CELL; SENILE PLAQUE;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; BRAIN; CAPILLARIES; CEREBELLUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED;

EID: 15844373497     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010050474     Document Type: Article

References (55)

1. Abraham CR, Selkoe DJ, Potter H (1988) Immunochemical identification of the serine protease inhibitor alpha-1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52: 487-501
2. Akiyama H, Kawamata T, Yamada T, Tooyama I, Ishii T, McGeer PL (1993) Expression of intercellular adhesion molecule (ICAM)-1 by a subset of astrocytes in Alzheimer disease and some other degenerative neurological disorders. Acta Neuropathol 85: 628-634
3. Birdsall HH, Lane C, Ramser MN, Anderson DC (1992) Induction of VCAM-1 and ICAM-1 on human neural cells and mechanisms of mononuclear leukocyte adherence. J Immunol 148: 2717-2723
4. Breitner JCS, Gau BA, Welsh KA, Plassman BL, McDonald WM, Helms MJ, Anthony JC (1994) Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology 44: 227-232
5. Das S, Potter H (1995) Expression of the Alzheimer amyloidpromoting factor antichymotrypsin is induced in human astrocytes by IL-1. Neuron 14: 447-456
6. Davies CA, Mann DMA (1993) Is the "preamyloid" of diffuse plaques in Alzheimer's disease really nonfibrillar? Am J Pathol 143: 1594-1605
7. Dickson DW, Lee SC, Mattiace LA, Yen SC, Brosnan C (1993) Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7: 75-83
8. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA (1986) Induction by IL-1 and interferon: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 137: 245-254
9. Eikelenboom P, Stam FC (1982) Immunoglobulins and complement factors in senile plaques. An immunohistochemical study. Acta Neuropathol (Berl) 57: 239-242
10. Frackowiak J, Zoltowska A, Wisniewski HM (1994) Non-fibrillar β-amyloid protein is associated with smooth muscle cells of vessel walls in Alzheimer disease. J Neuropathol Exp Neurol 53: 637-645
11. Giulian D, Baker TJ, Shih LN, Lachman LB (1986) Interleukin 1 of the central nervous system is produced by ameboid microglia. J Exp Med 164: 594-604
12. Glenner GG, Wong CW (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120: 885-890
13. Griffin WST, Stanley LC, Ling C, White L, MacLeod V, Perror LJ, White III CL, Araoz C (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 86: 7611-7615
14. Griffin WST, Sheng JG, Roberts GW, Mrak RE (1995) Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J Neuropathol Exp Neurol 54: 276-281
15. Haass C, Selkoe DJ (1993) Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide. Cell 75: 1039-1042
16. Iwamoto N, Nishiyama E, Ohwada J, Arai H (1994) Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: immunohistochemical study using formic acid pretreatment of tissue sections. Neurosci Lett 177: 23-26
17. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y (1994) Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 13: 45-53
18. Jarrett JT, Berger EP, Lansbury PT (1993) The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32: 4693-4697
19. Joachim CL, Morris JH, Selkoe DJ (1989) Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease. Am J Pathol 135: 309-319
20. Kalaria RN, Perry G (1993) Amyloid P component and other acute-phase proteins associated with cerebellar Aβ-deposits in Alzheimer's disease. Brain Res 631: 151-155
21. Kang J, Lemaire H, Unterbeck A, Salbaum JM, Masters CL, Grzeschik K, Multhaup G, Beyreuther K, Müller-Hill B (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733-736
22. Khachaturian ZS (1985) Diagnosis of Alzheimer's disease. Arch Neurol 42: 1097-1104
23. Ma J, Yee A, Brewer BJ, Das S, Potter H (1994) Amyloid associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372: 92-94
24. Mann DM, Jones D, Prinja D, Purkiss MS (1990) The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease. Acta Neuropathol 80: 318-327
25. Mattiace LA, Davies P, Yen S-H, Dickson DW (1990) Microglia in cerebellar plaques in Alzheimer's disease. Acta Neuropathol 80: 493-498
26. Miller DL, Papayannopoulos IA, Styles J, Bobin SA, Lin YY, Biemann K, Iqbal K (1993) Peptide composition of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch Biochem Biophys 301: 41-52
27. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Belle G van, Berg L (1991) The consortium to establish a registry for Alzheimer's Disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486
28. Murphy GMJ, Forno LS, Higgins L, Scardina JM, Eng FL, Cordell B (1994) Development of a monoclonal antibody specific for the COOH-terminal of β-amyloid 1-42 and its immunohistochemical reactivity in Alzheimer's disease and related disorders. Am J Pathol 144: 1082-1088
29. Pasternack JM, Abraham CR, Van Dyke BJ, Potter H, Younkin SG (1989) Astrocytes in Alzheimer's disease gray matter express α1-antichymotrypsin mRNA. Am J Pathol 135: 827-834
30. Prelli F, Castafio E, Glenner CG, Frangione B (1988) Differences between vascular and plaque core amyloid in Alzheimer's disease. J Neurochem 51: 648-651
31. Rogers J, Kirby LC, Hempelman SR, Berry DL, McGeer PL, Kaszniak AW, Zalinski J, Cofield M, Mansukhani L, Wilson P, Kogan F (1993) Clinical trial of indomethacin in Alzheimer's disease. Neurology 43: 1609-1611
32. Roher AE, Lowenson JD, Clarke S, Woods AS, Cotter RJ, Cowing E, Ball MJ (1993) β-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. Proc Natl Acad Sci USA 90: 10836-10840
33. Rothlein R, Dustin ML, Marlin SD, Springer TA (1986) A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol 137: 1270-1274
34. Rozemuller JM, Eikelenboom P, Stam FC, Beyreuther K, Masters CL (1989) A4 protein in Alzheimer's disease: primary and secondary cellular events in extracellular amyloid deposition. J Neuropathol Exp Neurol 48: 674-691
35. Rozemuller JM, Stam FC, Eikelenboom P (1990) Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease. Neurosci Lett 119: 75-78
36. Rozemuller JM, Abbink JJ, Kamp AM, Stam FC, Hack CE, Eikelenboom P (1991) Distribution pattern and functional state of α1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. Acta Neuropathol 82: 200-207
37. Rozemuller JM, Bots GTAM, Roos RAC, Eikelenboom P (1992) Acute phase proteins but not activated microglial cells are present in parenchymal β/A4 deposits in the brains of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type. Neurosci Lett 140: 137-140
38. Sanan DA, Weisgraber KH, Russell SJ, Mahley RW, Huang D, Saunders A, Schemel D, Wisniewski T, Frangione B, Roses AD, Strittmatter WJ (1994) Apolipoprotein E associates with β amyloid peptide of Alzheimer's disease to form novel monofibrils. J Clin Invest 94: 860-869
39. Sébire G, Emilie D, Wallon C, Héry C, Devergne O, Delfraissy J, Galanaud P, Tardieu M (1993) In vitro production of IL-6, IL-1β and tumor necrosis factor-α by human embryonic microglial and neural cells. J Immunol 150: 1517-1523
40. Selkoe DJ (1991) The molecular pathology of Alzheimer's disease. Neuron 6: 487-498
41. Shoji M, Hirai S, Yamaguchi H, Harigaya Y, Ishiguro K, Matsubara E (1991) Alpha 1-antichymotrypsin is present in diffuse senile plaques. Am J Pathol 138: 247-257
42. Shoji M, Golde TE, Ghiso J, Cheung TT, Estus S, Shaffer LM, Cai X-D, McKay DM, Tintner R, Frangione B, Younkin SG (1992) Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258: 126-129
43. Snow AD, Sekiguchi R, Nochlin D, Fraser P, Kimata K, Mizutani A, Arai M, Schreier WA, Morgan DG (1994) An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain. Neuron 12: 219-234
44. Snow AD, Sekiguchi RT, Nochlin D, Kalaria RN, Kimata K (1994) Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain. Am J Pathol 144: 337-347
45. Tooyama I, Kimura H, Akiyama H, McGeer PL (1990) Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease. Brain Res 523: 273-280
46. Van Nostrand WE, Wagner SL, Suzuki M, Choi BH, Farrow JS, Geddes JW, Cotman CW, Cunningham DD (1989) Protease nexin-II, a potent anti-chymotrypsin, shows identity to amyloid β-protein precursor. Nature 341: 546-549
47. Verbeek MM, Otte-Höller I, Westphal JR, Wesseling P, Ruiter DJ, Waal RMW de (1994) Accumulation of intercellular adhesion molecule-1 in senile plaques in brain tissue of patients with Alzheimer's disease. Am J Pathol 144: 104-116
48. Verbeek MM, Otte-Höller I, Wesseling P, Van Nostrand WE, Sorg C, Ruiter DJ, Waal RMW de (1995) A lysosomal marker for activated microglial cells involved in Alzheimer classic senile plaques. Acta Neuropathol 90: 493-503
49. Verbeek MM, Westphal JR, Ruiter DJ, Waal RMW de (1995) T lymphocyte adhesion to human brain pericytes is mediated via VLA-4/VCAM-1 interactions. J Immunol 154: 5876-5884
50. Westphal JR, Willems HW, Schalkwijk CJM, Ruiter DJ, Waal RMW de (1993) A new 180-kDa dermal endothelial cell activation antigen: in vitro and in situ characteristics. J Invest Dermatol 100: 27-34
51. Wisniewski T, Castano EM, Golabek A, Vogel T, Frangione B (1994) Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am J Pathol 145: 1030-1035
52. Wong D, Dorovini-Zis K (1992) Upregulation of intercellular adhesion molecule-1 (ICAM-1) expression in primary cultures of human brain microvessel endothelial cells by cytokines and lipopolysaccharide. J Neuroimmunol 39: 11-22
53. Yamaguchi H, Hirai S, Morimatsu M, Shoji M, Nakazato Y (1989) Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated by beta protein immunostain. Acta Neuropathol 77: 314-319
54. Yamaguchi H, Ishiguro K, Sugihara S, Nakazato Y, Kawarabayashi T, Sun X, Hirai S (1994) Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer β-amyloid deposition. Acta Neuropathol 88: 413-419
55. Yamazaki T, Yamaguchi H, Nakazato Y, Ishiguro K, Kawarabayashi T, Hirai S (1992) Ultrastructural characterization of cerebellar diffuse plaques in Alzheimer's disease. J Neuropathol Exp Neurol 51: 281-286